rs5030728

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_138554.5(TLR4):​c.261-385G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.231 in 152,130 control chromosomes in the GnomAD database, including 4,568 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.23 ( 4568 hom., cov: 33)

Consequence

TLR4
NM_138554.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.538

Publications

80 publications found
Variant links:
Genes affected
TLR4 (HGNC:11850): (toll like receptor 4) The protein encoded by this gene is a member of the Toll-like receptor (TLR) family which plays a fundamental role in pathogen recognition and activation of innate immunity. TLRs are highly conserved from Drosophila to humans and share structural and functional similarities. They recognize pathogen-associated molecular patterns that are expressed on infectious agents, and mediate the production of cytokines necessary for the development of effective immunity. The various TLRs exhibit different patterns of expression. In silico studies have found a particularly strong binding of surface TLR4 with the spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of Coronavirus disease-2019 (COVID-19). This receptor has also been implicated in signal transduction events induced by lipopolysaccharide (LPS) found in most gram-negative bacteria. Mutations in this gene have been associated with differences in LPS responsiveness, and with susceptibility to age-related macular degeneration. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2020]
TLR4 Gene-Disease associations (from GenCC):
  • inflammatory bowel disease
    Inheritance: AR Classification: LIMITED Submitted by: PanelApp Australia

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.296 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_138554.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TLR4
NM_138554.5
MANE Select
c.261-385G>A
intron
N/ANP_612564.1O00206-1
TLR4
NM_003266.4
c.141-385G>A
intron
N/ANP_003257.1O00206-2
TLR4
NM_138557.3
c.-340-385G>A
intron
N/ANP_612567.1O00206-3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TLR4
ENST00000355622.8
TSL:1 MANE Select
c.261-385G>A
intron
N/AENSP00000363089.5O00206-1
TLR4
ENST00000394487.5
TSL:1
c.141-385G>A
intron
N/AENSP00000377997.4O00206-2
ENSG00000285082
ENST00000697666.1
c.140+3275G>A
intron
N/AENSP00000513391.1A0A8V8TMK6

Frequencies

GnomAD3 genomes
AF:
0.231
AC:
35087
AN:
152012
Hom.:
4567
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.140
Gnomad AMI
AF:
0.373
Gnomad AMR
AF:
0.233
Gnomad ASJ
AF:
0.245
Gnomad EAS
AF:
0.00250
Gnomad SAS
AF:
0.220
Gnomad FIN
AF:
0.239
Gnomad MID
AF:
0.315
Gnomad NFE
AF:
0.299
Gnomad OTH
AF:
0.249
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.231
AC:
35092
AN:
152130
Hom.:
4568
Cov.:
33
AF XY:
0.226
AC XY:
16820
AN XY:
74360
show subpopulations
African (AFR)
AF:
0.140
AC:
5803
AN:
41510
American (AMR)
AF:
0.233
AC:
3557
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.245
AC:
847
AN:
3464
East Asian (EAS)
AF:
0.00270
AC:
14
AN:
5178
South Asian (SAS)
AF:
0.220
AC:
1061
AN:
4820
European-Finnish (FIN)
AF:
0.239
AC:
2527
AN:
10580
Middle Eastern (MID)
AF:
0.305
AC:
89
AN:
292
European-Non Finnish (NFE)
AF:
0.299
AC:
20333
AN:
67984
Other (OTH)
AF:
0.246
AC:
521
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1369
2738
4106
5475
6844
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
386
772
1158
1544
1930
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.275
Hom.:
9304
Bravo
AF:
0.227
Asia WGS
AF:
0.102
AC:
359
AN:
3474

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
CADD
Benign
8.3
DANN
Benign
0.54
PhyloP100
0.54
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs5030728; hg19: chr9-120474282; COSMIC: COSV62922754; COSMIC: COSV62922754; API